We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Salesforce
CRM
$134B
| $837K | ﹤0.01% |
10,156
+1,341
| +15% | +$107K |
|
727
Varex Imaging
VREX
$460M
| $834K | ﹤0.01% |
+24,874
| New | +$787K |
|
728
Vulcan Materials
VMC
$36.3B
| $831K | ﹤0.01% |
6,911
-462
| -6% | -$56.5K |
|
|
FBC
729
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $825K | ﹤0.01% |
29,280
-3,500
| -11% | -$95.2K |
|
|
BLD
730
DELISTED
TopBuild
BLD
| $820K | ﹤0.01% |
17,466
| – | – |
|
731
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $815K | ﹤0.01% |
17,088
+1,660
| +11% | +$78.3K |
|
732
Qiagen
QGEN
$8.53B
| $815K | ﹤0.01% |
+26,573
| New | +$819K |
|
733
Vanguard Health Care ETF
VHT
$18.2B
| $812K | ﹤0.01% |
5,898
-270
| -4% | -$36.4K |
|
734
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
| $810K | ﹤0.01% |
7,746
+6,766
| +690% | +$689K |
|
|
INVX
735
Innovex International
INVX
$1.87B
| $808K | ﹤0.01% |
14,832
+4,136
| +39% | +$247K |
|
736
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
| $806K | ﹤0.01% |
34,655
+11,170
| +48% | +$260K |
|
737
VanEck Gold Miners ETF
GDX
$23B
| $805K | ﹤0.01% |
35,330
+751
| +2% | +$17.5K |
|
738
Provident Financial Services
PFS
$3.11B
| $805K | ﹤0.01% |
31,146
-1,514
| -5% | -$40.1K |
|
739
Glaukos
GKOS
$9.02B
| $803K | ﹤0.01% |
15,680
+680
| +5% | +$29.6K |
|
740
Brown-Forman Class B
BF.B
$12B
| $792K | ﹤0.01% |
26,858
+731
| +3% | +$21.7K |
|
|
ILG
741
DELISTED
ILG, Inc Common Stock
ILG
| $790K | ﹤0.01% |
37,731
| – | – |
|
742
Charter Communications
CHTR
$14.7B
| $788K | ﹤0.01% |
2,411
+1,964
| +439% | +$626K |
|
|
RTEC
743
DELISTED
Rudolph Technologies Inc
RTEC
| $787K | ﹤0.01% |
35,170
+142
| +0.4% | +$3.17K |
|
744
Ericsson
ERIC
$30.7B
| $786K | ﹤0.01% |
118,530
-7,866
| -6% | -$48.5K |
|
745
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
| $785K | ﹤0.01% |
14,685
+1,429
| +11% | +$73.9K |
|
746
Boston Scientific
BSX
$65.8B
| $781K | ﹤0.01% |
31,443
-6,810
| -18% | -$166K |
|
747
Keysight
KEYS
$54.5B
| $780K | ﹤0.01% |
21,619
-2,171
| -9% | -$80.8K |
|
|
HA
748
DELISTED
Hawaiian Holdings, Inc.
HA
| $775K | ﹤0.01% |
16,698
| – | – |
|
749
Louisiana-Pacific
LPX
$5.2B
| $769K | ﹤0.01% |
+30,997
| New | +$685K |
|
|
WPZ
750
DELISTED
Williams Partners L.P.
WPZ
| $769K | ﹤0.01% |
18,846
+1,200
| +7% | +$48.2K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.